{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:48:49Z","timestamp":1789778929928,"version":"4.0.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Medical Research Council, Cancer Research UK"},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Wellcome trust"},{"name":"Gates Cambridge scholarship"}],"content-domain":{"domain":["thebonejournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.bone.2013.05.009","type":"journal-article","created":{"date-parts":[[2013,5,20]],"date-time":"2013-05-20T16:26:26Z","timestamp":1369067186000},"page":"67-72","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["C-reactive protein and fracture risk: European Prospective Investigation into Cancer Norfolk Study"],"prefix":"10.1016","volume":"56","author":[{"given":"Sara","family":"Ahmadi-Abhari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert N.","family":"Luben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J.","family":"Wareham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kay-Tee","family":"Khaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2013.05.009_bb0005","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.yexmp.2005.11.004","article-title":"Inflammation markers predicting frailty and mortality in the elderly","volume":"80","author":"De","year":"2006","journal-title":"Exp Mol Pathol"},{"key":"10.1016\/j.bone.2013.05.009_bb0010","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1016\/j.febslet.2005.02.055","article-title":"Inflamm-ageing and lifelong antigenic load as major determinants of ageing rate and longevity","volume":"579","author":"De","year":"2005","journal-title":"FEBS Lett"},{"key":"10.1016\/j.bone.2013.05.009_bb0015","first-page":"218","article-title":"Inflammaging (inflammation+aging): a driving force for human aging based on an evolutionarily antagonistic pleiotropy theory?","volume":"2","author":"Goto","year":"2008","journal-title":"Biosci Trends"},{"key":"10.1016\/j.bone.2013.05.009_bb0020","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1159\/000156466","article-title":"Immunosenescence and immunogenetics of human longevity","volume":"15","author":"Ostan","year":"2008","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.bone.2013.05.009_bb0025","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0140-6736(09)61717-7","article-title":"C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis","volume":"375","author":"Kaptoge","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.bone.2013.05.009_bb0030","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1056\/NEJMoa032804","article-title":"C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease","volume":"350","author":"Danesh","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bone.2013.05.009_bb0035","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1001\/archinte.165.21.2473","article-title":"C-reactive protein and risk of cardiovascular disease in men and women from the Framingham Heart Study","volume":"165","author":"Wilson","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.bone.2013.05.009_bb0040","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1158\/1055-9965.EPI-05-0316","article-title":"Circulating levels of inflammatory markers and cancer risk in the health aging and body composition cohort","volume":"14","author":"Il'yasova","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.bone.2013.05.009_bb0045","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10552-008-9212-z","article-title":"Associations of circulating C-reactive protein and interleukin-6 with cancer risk: findings from two prospective cohorts and a meta-analysis","volume":"20","author":"Heikkila","year":"2009","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.bone.2013.05.009_bb0050","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1007\/s00125-009-1338-3","article-title":"Association of C-reactive protein with type 2 diabetes: prospective analysis and meta-analysis","volume":"52","author":"Lee","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.bone.2013.05.009_bb0055","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.2337\/dc07-0348","article-title":"Risk of type 2 diabetes attributable to C-reactive protein and other risk factors","volume":"30","author":"Dehghan","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bone.2013.05.009_bb0060","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1001\/jama.290.22.2945","article-title":"C-reactive protein and the risk of developing hypertension","volume":"290","author":"Sesso","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.bone.2013.05.009_bb0065","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jalz.2009.04.1230","article-title":"Elevated C-reactive protein levels are associated with prevalent dementia in the oldest-old","volume":"5","author":"Kravitz","year":"2009","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.bone.2013.05.009_bb0070","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1164\/rccm.200810-1540OC","article-title":"C-reactive protein levels, haplotypes, and the risk of incident chronic obstructive pulmonary disease","volume":"179","author":"van Durme","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.bone.2013.05.009_bb0075","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1136\/thx.2009.131193","article-title":"C reactive protein and chronic obstructive pulmonary disease: a Mendelian randomisation approach","volume":"66","author":"Dahl","year":"2011","journal-title":"Thorax"},{"key":"10.1016\/j.bone.2013.05.009_bb0080","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1590\/S0004-27302010000200007","article-title":"Osteoporosis and inflammation","volume":"54","author":"Lacativa","year":"2010","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"10.1016\/j.bone.2013.05.009_bb0085","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.0105-2896.2005.00338.x","article-title":"Rheumatic diseases: the effects of inflammation on bone","volume":"208","author":"Walsh","year":"2005","journal-title":"Immunol Rev"},{"key":"10.1016\/j.bone.2013.05.009_bb0090","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0140-6736(94)91049-9","article-title":"Generalised bone loss in patients with early rheumatoid arthritis","volume":"344","author":"Gough","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.bone.2013.05.009_bb0095","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/ncprheum0298","article-title":"Therapy insight: osteoporosis and osteonecrosis in systemic lupus erythematosus","volume":"2","author":"Lane","year":"2006","journal-title":"Nat Clin Pract Rheumatol"},{"key":"10.1016\/j.bone.2013.05.009_bb0100","doi-asserted-by":"crossref","first-page":"795","DOI":"10.7326\/0003-4819-133-10-200011210-00012","article-title":"The incidence of fracture among patients with inflammatory bowel disease. A population-based cohort study","volume":"133","author":"Bernstein","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bone.2013.05.009_bb0105","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.0105-2896.2005.00334.x","article-title":"The role of the immune system in the pathophysiology of osteoporosis","volume":"208","author":"Clowes","year":"2005","journal-title":"Immunol Rev"},{"key":"10.1016\/j.bone.2013.05.009_bb0110","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.mehy.2010.09.023","article-title":"Inflammaging: the driving force in osteoporosis?","volume":"76","author":"Lencel","year":"2011","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.bone.2013.05.009_bb0115","article-title":"Association between bone mineral density and C-reactive protein in a large population-based sample","volume":"10","author":"de","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.bone.2013.05.009_bb0120","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1210\/jc.2007-2325","article-title":"Circulating levels of inflammatory markers predict change in bone mineral density and resorption in older adults: a longitudinal study","volume":"93","author":"Ding","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bone.2013.05.009_bb0125","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1007\/s00198-005-1840-5","article-title":"Higher circulating hsCRP levels are associated with lower bone mineral density in healthy pre- and postmenopausal women: evidence for a link between systemic inflammation and osteoporosis","volume":"16","author":"Koh","year":"2005","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.bone.2013.05.009_bb0130","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1359\/jbmr.070409","article-title":"Inflammatory markers and incident fracture risk in older men and women: the Health Aging and Body Composition Study","volume":"22","author":"Cauley","year":"2007","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2013.05.009_bb0135","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1001\/archinte.166.22.2495","article-title":"High-sensitivity C-reactive protein and risk of nontraumatic fractures in the Bruneck study","volume":"166","author":"Schett","year":"2006","journal-title":"Arch Intern Med"},{"issue":"296","key":"10.1016\/j.bone.2013.05.009_bb0140","first-page":"1353","article-title":"High-sensitivity C-reactive protein and fracture risk in elderly women","volume":"20","author":"Pasco","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.bone.2013.05.009_bb0145","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1007\/s00198-010-1425-9","article-title":"C-reactive protein predicts incident fracture in community-dwelling elderly Japanese women: the Muramatsu study","volume":"22","author":"Nakamura","year":"2011","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.bone.2013.05.009_bb0150","article-title":"C-reactive protein, bone strength, and 9-year fracture risk: data from the study of women's health across the nation (SWAN)","volume":"10","author":"Ishii","year":"2013","journal-title":"J Bone Miner Res"},{"issue":"Suppl. 1","key":"10.1016\/j.bone.2013.05.009_bb0155","first-page":"95","article-title":"EPIC-Norfolk: study design and characteristics of the cohort. European Prospective Investigation of Cancer","volume":"80","author":"Day","year":"1999","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bone.2013.05.009_bb0160","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1079\/PHN2002439","article-title":"Validity and repeatability of a simple index derived from the short physical activity questionnaire used in the European Prospective Investigation into Cancer and Nutrition (EPIC) study","volume":"6","author":"Wareham","year":"2003","journal-title":"Public Health Nutr"},{"key":"10.1016\/j.bone.2013.05.009_bb0165","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0140-6736(03)15325-1","article-title":"Prediction of total and hip fracture risk in men and women by quantitative ultrasound of the calcaneus: EPIC-Norfolk prospective population study","volume":"363","author":"Khaw","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.bone.2013.05.009_bb0170","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1007\/s00198-004-1721-3","article-title":"Calcaneum broadband ultrasound attenuation relates to vegetarian and omnivorous diets differently in men and women: an observation from the European Prospective Investigation into Cancer in Norfolk (EPIC-Norfolk) population study","volume":"16","author":"Welch","year":"2005","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.bone.2013.05.009_bb0175","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1002\/jbmr.1559","article-title":"Inflammatory markers and the risk of hip fracture: the Women's Health Initiative","volume":"27","author":"Barbour","year":"2012","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2013.05.009_bb0180","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1186\/1471-2458-10-579","article-title":"The relationship of high sensitivity C-reactive protein to percent body fat mass, body mass index, waist-to-hip ratio, and waist circumference in a Taiwanese population","volume":"10","author":"Lin","year":"2010","journal-title":"BMC Public Health"},{"key":"10.1016\/j.bone.2013.05.009_bb0185","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1161\/CIRCULATIONAHA.107.710509","article-title":"Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study","volume":"116","author":"Pou","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.bone.2013.05.009_bb0190","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/j.1365-2796.2011.02443.x","article-title":"Body fat mass is a predictor of risk of osteoporotic fractures in women but not in men: a prospective population study","volume":"271","author":"Moayyeri","year":"2012","journal-title":"J Intern Med"},{"key":"10.1016\/j.bone.2013.05.009_bb0195","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.thromres.2004.12.005","article-title":"Comparison of soluble thrombomodulin, von Willebrand factor, tPA\/PAI-1 complex, and high-sensitivity CRP concentrations in serum, EDTA plasma, citrated plasma, and acidified citrated plasma (Stabilyte) stored at \u221270 degrees C for 8\u201311years","volume":"116","author":"Nilsson","year":"2005","journal-title":"Thromb Res"},{"key":"10.1016\/j.bone.2013.05.009_bb0200","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1359\/jbmr.090212","article-title":"Is QUS or DXA better for predicting the 10-year absolute risk of fracture?","volume":"24","author":"Moayyeri","year":"2009","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2013.05.009_bb0205","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1359\/JBMR.051205","article-title":"Long-term fracture prediction by DXA and QUS: a 10-year prospective study","volume":"21","author":"Stewart","year":"2006","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2013.05.009_bb0210","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/BF01623454","article-title":"The role of ultrasound in the assessment of osteoporosis: a review","volume":"7","author":"Njeh","year":"1997","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.bone.2013.05.009_bb0215","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.molimm.2004.09.028","article-title":"CRP after 2004","volume":"42","author":"Agrawal","year":"2005","journal-title":"Mol Immunol"},{"key":"10.1016\/j.bone.2013.05.009_bb0220","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.clim.2005.08.004","article-title":"C-reactive protein: ligands, receptors and role in inflammation","volume":"117","author":"Marnell","year":"2005","journal-title":"Clin Immunol"},{"key":"10.1016\/j.bone.2013.05.009_bb0225","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S1537-1891(02)00294-X","article-title":"The biological functions of C-reactive protein","volume":"39","author":"Szalai","year":"2002","journal-title":"Vascul Pharmacol"}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328213001919?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328213001919?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T12:06:56Z","timestamp":1588939616000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328213001919"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S8756328213001919"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2013.05.009","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"C-reactive protein and fracture risk: European Prospective Investigation into Cancer Norfolk Study","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2013.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}